Dow Down0.37% Nasdaq Down0.25%

Cytokinetics, Incorporated (CYTK)

-NasdaqCM
4.37 Down 0.04(0.91%) 11:20AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 7,788   7,979   24,349   4,469  
Cost of Revenue -   -   -   -  
Gross Profit 7,788   7,979   24,349   4,469  
Operating Expenses
Research Development11,737  12,490  13,824  13,445  
Selling General and Administrative4,458  4,259  4,093  3,635  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (8,407) (8,770) 6,432   (12,611)
Income from Continuing Operations
Total Other Income/Expenses Net -   -  99   -  
Earnings Before Interest And Taxes(8,374)(8,744)6,531  (12,588)
Interest Expense -   -   -   -  
Income Before Tax(8,374)(8,744)6,531  (12,588)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(8,374)(8,744)6,531  (12,588)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (8,374) (8,744) 6,531   (12,588)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (8,374) (8,744) 6,531   (12,588)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.